AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30982861 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucoraphanin-rich broccoli soup (300 mL weekly)
Number of subjects: 49
Study 30982861 — intervention group
Group type: COMPARATOR
Intervention: Control (standard broccoli soup, 300 mL weekly)
Number of subjects: 49
Study 28453446 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilization with manual cervical traction (NMCT)
Number of subjects: 30
Study 28453446 — intervention group
Group type: COMPARATOR
Intervention: Manual cervical traction (MCT)
Number of subjects: 30
Study 26486855 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin (Xeomin, Merz, Germany; 50 U/1 mL at each fat pad)
Number of subjects: 60
Study 26486855 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% normal saline, 1 mL at each fat pad)
Number of subjects: 60
Study 23717976 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Xiatianwu tablets (2 tablets each time, 3 times/day for 3 months)
Number of subjects: 180
Study 23717976 — intervention group
Group type: COMPARATOR
Intervention: Leflunomide, sulfasalazine, and celecoxib (control group)
Number of subjects: 180
Study 23717976 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiatianwu group (not specified dosage or duration)
Number of subjects: 180
Study 22107692 — intervention group
Group type: EXPERIMENTAL
Intervention: Regional citrate anticoagulation (RCA)
Number of subjects: 20
Study 22107692 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 20
Study 19035979 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (5 mg/day)
Number of subjects: 39
Study 19035979 — intervention group
Group type: COMPARATOR
Intervention: Alfacalcidol (1 microg/day)
Number of subjects: 39
Study 18186963 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Number of subjects: 92
Study 18186963 — intervention group
Group type: COMPARATOR
Intervention: RAD001
Number of subjects: 92
Study 15031272 — intervention group
Group type: EXPERIMENTAL
Intervention: Life-skills approach intervention consisting of 21 sessions over 4 months.
Number of subjects: 1024
Study 15031272 — intervention group
Group type: COMPARATOR
Intervention: Control group with no specific intervention.
Number of subjects: 1024
Study 11394462 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-interval observational protocols
Number of subjects: 5
Study 11394462 — intervention group
Group type: COMPARATOR
Intervention: Electronic postural assessment system with video analysis
Number of subjects: 5
Study 9713670 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) - diet intervention consisting of interactive mailings, computer‐generated phone calls, and classes for 6 months.
Number of subjects: 165
Study 9713670 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) - control group receiving standard care without the diet intervention.
Number of subjects: 165
Study 9713670 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SI vs UC
Number of subjects: 165
Study 8028316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 children listened to a variety of correctly and incorrectly produced versions of the word 'shoe'
Number of subjects: 27
Study 8028316 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 children listened to the words 'shoe' and 'moo'
Number of subjects: 27
Study 8028316 — intervention group
Group type: COMPARATOR
Intervention: Group 3 children listened to the words 'cat' and 'Pete'
Number of subjects: 27
Study 2659299 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Contact Casting (TCC)
Number of subjects: 40
Study 2659299 — intervention group
Group type: COMPARATOR
Intervention: Traditional Dressing Treatment (TDT)
Number of subjects: 40
Study 235714 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrallazine
Number of subjects: 0
Study 235714 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 0
Study 235714 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazoxide
Number of subjects: 0
Study 235714 — intervention group
Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 0
Study 31870438 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA (Ambulatory Medical Assistance)
Number of subjects: 100
Study 31870438 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 100
Study 31870438 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA and Control group
Number of subjects: 100
Study 28477375 — intervention group
Group type: EXPERIMENTAL
Intervention: l-tyrosine (150 mg kg-1)
Number of subjects: 22
Study 28477375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 26134076 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (Zn sulfate 70 mg daily for 16 weeks)
Number of subjects: 25
Study 26134076 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical capsules containing wheat starch with no added Zn)
Number of subjects: 25
Study 26134076 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group with Zinc supplementation (Zn sulfate 70 mg daily for 16 weeks)
Number of subjects: 25
Study 26134076 — intervention group
Group type: COMPARATOR
Intervention: Control group with Placebo (identical capsules containing wheat starch with no added Zn)
Number of subjects: 25
Study 23343453 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine (TR-C group)
Number of subjects: 64
Study 23343453 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical antipsychotics other than clozapine (NTR group)
Number of subjects: 64
Study 23343453 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 64
Study 23343453 — intervention group
Group type: EXPERIMENTAL
Intervention: NTR group
Number of subjects: 64
Study 23343453 — intervention group
Group type: EXPERIMENTAL
Intervention: TR-C group
Number of subjects: 64
Study 21219223 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine infusion
Number of subjects: 65
Study 21219223 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 65
Study 18583448 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telecare for management of acute exacerbations of COPD
Number of subjects: 20
Study 16920550 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen-codeine
Number of subjects: 60
Study 16920550 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 60
Study 16920550 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 12900093 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed decision aid plus worksheet
Number of subjects: 34
Study 12900093 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet
Number of subjects: 34
Study 10717524 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast conserving operation with postoperative radiotherapy
Number of subjects: 331
Study 10717524 — intervention group
Group type: COMPARATOR
Intervention: Breast conserving operation without postoperative radiotherapy
Number of subjects: 331
Study 8940320 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling and support intervention (6 sessions of individual and family counseling within 4 months and support groups)
Number of subjects: 206
Study 8940320 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling and support intervention
Number of subjects: 206
Study 1587959 — intervention group
Group type: EXPERIMENTAL
Intervention: bezafibrate (400 mg daily)
Number of subjects: 13
Study 1587959 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin (20 mg daily)
Number of subjects: 13
Study 1587959 — intervention group
Group type: EXPERIMENTAL
Intervention: combined bezafibrate-simvastatin
Number of subjects: 13
Study 1587959 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 13
Study 3896372 — intervention group
Group type: EXPERIMENTAL
Intervention: Single layer interrupted extramucosal sutures
Number of subjects: 118
Study 3896372 — intervention group
Group type: COMPARATOR
Intervention: Circular staple gun
Number of subjects: 118
Study 31444196 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 29505603 — intervention group
Group type: EXPERIMENTAL
Intervention: Fear Avoidance Model (FAM) variables including BDI and FABQ-work subscale
Number of subjects: 60
Study 29505603 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline FAM measures
Number of subjects: 60
Study 27716422 — intervention group
Group type: EXPERIMENTAL
Intervention: YXBCM01 granule 5.5 g twice daily for 12 weeks
Number of subjects: 600
Study 27716422 — intervention group
Group type: COMPARATOR
Intervention: Placebo granules 5.5 g twice daily for 12 weeks
Number of subjects: 600
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: CADEES items related to insurance coverage of eye examination costs
Number of subjects: 316
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: CADEES items related to general barriers to obtaining eye examinations
Number of subjects: 316
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: CADEES items related to prioritizing eye examinations
Number of subjects: 316
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: CADEES items related to awareness of diabetic eye disease visibility through examination
Number of subjects: 316
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower hemoglobin A1c levels
Number of subjects: 316
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: Having insurance
Number of subjects: 316
Study 24518614 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration of diabetes
Number of subjects: 316
Study 22898340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT) performed 3 times within 3 months (Group A, n = 20)
Number of subjects: 55
Study 22898340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT) performed 3 sessions/week for 1 month (Group B, n = 21)
Number of subjects: 55
Study 22898340 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14) received only medical therapy
Number of subjects: 55
Study 20594339 — intervention group
Group type: EXPERIMENTAL
Intervention: Test for Substitution Patterns (TSP)
Number of subjects: 53
Study 18060588 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mL orange juice (containing 0.545 g PB)
Number of subjects: 8
Study 18060588 — intervention group
Group type: EXPERIMENTAL
Intervention: PB supplement (0.545 g PB dissolved in 750 mL apple juice)
Number of subjects: 8
Study 18060588 — intervention group
Group type: COMPARATOR
Intervention: 750 mL apple juice (control)
Number of subjects: 8
Study 14984384 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered acetylsalicylic acid plus ascorbic acid
Number of subjects: 17
Study 14984384 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid plus paracetamol plus caffeine
Number of subjects: 17
Study 11334921 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen citrate (TMX)
Number of subjects: 86
Study 11334921 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 86
Study 9656904 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue positioned against the anterior palate
Number of subjects: 33
Study 9656904 — intervention group
Group type: COMPARATOR
Intervention: Tongue on the floor of the mouth
Number of subjects: 33
Study 8184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model plus verbal rehearsal
Number of subjects: 80
Study 8184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model, verbal rehearsal plus cues
Number of subjects: 80
Study 8184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model plus cues
Number of subjects: 80
Study 8184209 — intervention group
Group type: COMPARATOR
Intervention: Visual model only
Number of subjects: 80
Study 8184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model plus cues (adults)
Number of subjects: 80
Study 8184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model plus verbal rehearsal (children)
Number of subjects: 80
Study 8184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual model, verbal rehearsal plus cues (children)
Number of subjects: 80
Study 3237227 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/kg phenobarbital
Number of subjects: 20
Study 3237227 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg phenobarbital
Number of subjects: 20
Study 30450925 — intervention group
Group type: EXPERIMENTAL
Intervention: β‐blocker uptitration
Number of subjects: 457
Study 30450925 — intervention group
Group type: COMPARATOR
Intervention: Control group (higher NPs levels)
Number of subjects: 457
Study 26900091 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy with cetuximab (Arm B)
Number of subjects: 102
Study 26900091 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy without cetuximab (Arm A)
Number of subjects: 102
Study 26900091 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (A and B)
Number of subjects: 102
Study 25605809 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 0
Study 25605809 — intervention group
Group type: COMPARATOR
Intervention: Baseline (before exercise)
Number of subjects: 0
Study 25605809 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise (after 12 weeks of aerobic exercise)
Number of subjects: 0
Study 25605809 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 0
Study 23875668 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-HPV using a standard wet transport medium (S-WET)
Number of subjects: 120
Study 23875668 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-HPV using a dry vaginal swab (S-DRY)
Number of subjects: 120
Study 23875668 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-sampling with Hybrid Capture HPV DNA test
Number of subjects: 120
Study 23875668 — intervention group
Group type: COMPARATOR
Intervention: Comparison of S-WET and S-DRY
Number of subjects: 120
Study 23875668 — intervention group
Group type: COMPARATOR
Intervention: Comparison of type-specific HPV agreement
Number of subjects: 120
Study 23875668 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-HPV tests
Number of subjects: 120
Study 20539274 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 44
Study 20539274 — intervention group
Group type: COMPARATOR
Intervention: Control (Atropine and Fentanyl without Rocuronium)
Number of subjects: 44
Study 19038683 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release of bFGF
Number of subjects: 40
Study 19038683 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release of bFGF combined with hCDCs
Number of subjects: 40
Study 19038683 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled release of bFGF combined with bone marrow-derived mesenchymal stem cells
Number of subjects: 40
Study 19038683 — intervention group
Group type: COMPARATOR
Intervention: Placebo medium
Number of subjects: 40
Study 16758263 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole (100 mg, first dose 200 mg)
Number of subjects: 12
Study 16758263 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (600 mg)
Number of subjects: 12
Study 16758263 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of itraconazole and gemfibrozil
Number of subjects: 12
Study 16758263 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12890944 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal steroid therapy
Number of subjects: 0
Study 12890944 — intervention group
Group type: COMPARATOR
Intervention: Guidelines for steroid use by the American Academy of Pediatrics and the Canadian Paediatric Society
Number of subjects: 0
Study 10864186 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervision by lay health worker (LHW)
Number of subjects: 156
Study 9103732 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral stress management (CBSM) intervention for 10 weeks
Number of subjects: 0
Study 9103732 — intervention group
Group type: COMPARATOR
Intervention: Modified waiting-list control group
Number of subjects: 0
Study 1555313 — intervention group
Group type: EXPERIMENTAL
Intervention: mainly rough food
Number of subjects: 150
Study 1555313 — intervention group
Group type: EXPERIMENTAL
Intervention: mainly soft food
Number of subjects: 150
Study 1555313 — intervention group
Group type: COMPARATOR
Intervention: no advice except to eat regularly
Number of subjects: 150
Study 6376596 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine withdrawal
Number of subjects: 81
Study 6376596 — intervention group
Group type: COMPARATOR
Intervention: Placebo withdrawal
Number of subjects: 81
Study 31675957 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent knowledge transfer intervention including educational group programme, decision support tool, and quarterly feedback report.
Number of subjects: 412
Study 31675957 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent knowledge transfer intervention.
Number of subjects: 412
Study 29177955 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate 6 g daily (N = 17)
Number of subjects: 35
Study 29177955 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 18)
Number of subjects: 35
Study 27053380 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal LCPUFA supplementation (1020 mg DHA plus 180 mg EPA/d)
Number of subjects: 112
Study 27053380 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 112
Study 27053380 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal LCPUFA supplementation
Number of subjects: 112
Study 25452635 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Contact Cast (TCC)
Number of subjects: 30
Study 25452635 — intervention group
Group type: COMPARATOR
Intervention: Pressure-Relieving Ankle Foot Orthosis (PRAFO)
Number of subjects: 30
Study 22377512 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER (3-12 mg/day)
Number of subjects: 766
Study 22377512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 766
Study 22377512 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine (5-20 mg/day)
Number of subjects: 766
Study 22377512 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 766
Study 22377512 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 766
Study 20223994 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise plus volume infusion (dextran)
Number of subjects: 21
Study 20223994 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 21
Study 20223994 — intervention group
Group type: COMPARATOR
Intervention: Volume infusion alone (dextran)
Number of subjects: 21
Study 18551025 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased left atrial systolic force (>14.33 kdyn)
Number of subjects: 567
Study 18551025 — intervention group
Group type: COMPARATOR
Intervention: Normal left atrial systolic force (≤14.33 kdyn)
Number of subjects: 567
Study 16004662 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance leaflet containing advice on reducing alcohol intake
Number of subjects: 361
Study 11952026 — intervention group
Group type: EXPERIMENTAL
Intervention: IM ertapenem 1 g once daily
Number of subjects: 117
Study 11952026 — intervention group
Group type: COMPARATOR
Intervention: IM ceftriaxone 1 g once daily
Number of subjects: 117
Study 10075344 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g raw flaxseed
Number of subjects: 9
Study 10075344 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g raw flaxseed
Number of subjects: 9
Study 10075344 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g raw flaxseed
Number of subjects: 9
Study 10075344 — intervention group
Group type: COMPARATOR
Intervention: 25 g processed flaxseed (muffin or bread)
Number of subjects: 9
Study 10075344 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g flaxseed (raw or processed)
Number of subjects: 9
Study 7722978 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-balloon device with prostaglandin E2 (PGE2) instillation
Number of subjects: 340
Study 7722978 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E2 (PGE2)
Number of subjects: 340
Study 2027481 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prednisone (0.75 mg/kg/d)
Number of subjects: 33
Study 2027481 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose prednisone (1.5 mg/kg/d)
Number of subjects: 33
Study 2027481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 6418647 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational health nurses (OHNs) monitoring
Number of subjects: 0
Study 6418647 — intervention group
Group type: COMPARATOR
Intervention: Regular care (RC) in the community
Number of subjects: 0
Study 30651222 — intervention group
Group type: COMPARATOR
Intervention: SIT (sitting on an office chair)
Number of subjects: 20
Study 30651222 — intervention group
Group type: COMPARATOR
Intervention: SIT-ACTIVE (sitting on a stability ball)
Number of subjects: 20
Study 30651222 — intervention group
Group type: COMPARATOR
Intervention: SIT-STAND (sitting with hourly 10-min standing interruptions)
Number of subjects: 20
Study 30010104 — intervention group
Group type: EXPERIMENTAL
Intervention: Bridging exercise with abdominal drawing-in maneuver (ADIM)
Number of subjects: 20
Study 30010104 — intervention group
Group type: COMPARATOR
Intervention: Bridging exercise without abdominal drawing-in maneuver (ADIM)
Number of subjects: 20
Study 27693664 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 778
Study 27693664 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 778
Study 25212541 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist counselling before starting chemotherapy
Number of subjects: 280
Study 25212541 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of information
Number of subjects: 280
Study 25212541 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of pharmacist counselling
Number of subjects: 280
Study 25212541 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up with the pharmacist after starting chemotherapy
Number of subjects: 280
Study 25212541 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude of pharmacist
Number of subjects: 280
Study 23064532 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based screening
Number of subjects: 200